The most commonly reported side effects of berahyaluronidase include hospitalisation, injection site pruritus, and injection site erythema, based on 2 FDA adverse event reports from 2025 to 2025.
Percentages show how often each reaction appears relative to total reports for berahyaluronidase.
These are voluntary reports and do not establish that berahyaluronidase caused these reactions.
Report severity
Seriousness is determined by the reporter, not by OpenClaim.
Other drugs that appear in adverse event reports alongside berahyaluronidase. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.